- Home
- SRPT vs VOR Comparison
SRPT vs VOR Comparison
Compare SRPT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- VOR
- Stock Information
- Founded
- SRPT 1980
- VOR 2015
- Country
- SRPT United States
- VOR United States
- Employees
- SRPT N/A
- VOR N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- SRPT Health Care
- VOR Health Care
- Exchange
- SRPT Nasdaq
- VOR Nasdaq
- Market Cap
- SRPT 1.9B
- VOR 207.1M
- IPO Year
- SRPT 1997
- VOR 2021
- Fundamental
- Price
- SRPT $16.22
- VOR $20.56
- Analyst Decision
- SRPT Hold
- VOR Buy
- Analyst Count
- SRPT 30
- VOR 6
- Target Price
- SRPT $35.85
- VOR $84.00
- AVG Volume (30 Days)
- SRPT 5.9M
- VOR 411.3K
- Earning Date
- SRPT 11-03-2025
- VOR 11-07-2025
- Dividend Yield
- SRPT N/A
- VOR N/A
- EPS Growth
- SRPT N/A
- VOR N/A
- EPS
- SRPT N/A
- VOR N/A
- Revenue
- SRPT $2,413,715,000.00
- VOR N/A
- Revenue This Year
- SRPT $10.20
- VOR N/A
- Revenue Next Year
- SRPT N/A
- VOR N/A
- P/E Ratio
- SRPT N/A
- VOR N/A
- Revenue Growth
- SRPT 47.15
- VOR N/A
- 52 Week Low
- SRPT $10.42
- VOR $2.62
- 52 Week High
- SRPT $138.81
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- SRPT 32.09
- VOR 34.33
- Support Level
- SRPT $22.80
- VOR $23.12
- Resistance Level
- SRPT $24.55
- VOR $26.76
- Average True Range (ATR)
- SRPT 1.30
- VOR 2.14
- MACD
- SRPT -0.50
- VOR -1.40
- Stochastic Oscillator
- SRPT 12.98
- VOR 8.04
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.